Cim Investment Management Inc Fibrogen Inc Transaction History

Cim Investment Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$12.02 - $16.79 $23,451 - $32,757	-1,951 Reduced 10.42%	16,765 $202,000
Q4 2021 May 19, 2022	SELL	$9.93 - $15.39 $185,849 - $288,039	-18,716 Reduced 50.0%	18,716 $264,000
Q4 2021 Feb 02, 2022	BUY	$9.93 - $15.39 $185,849 - $288,039	18,716 Added 100.0%	37,432 $455,000
Q3 2021 Nov 15, 2021	BUY	$10.18 - $26.64 $190,528 - $498,594	18,716 New	18,716 $191,000
Q3 2020 Nov 16, 2020	SELL	$40.47 - $45.5 $264,390 - $297,251	-6,533 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$32.57 - $42.83 $212,779 - $279,808	6,533 New	6,533 $265,000
Q4 2019 Feb 14, 2020	SELL	$34.58 - $48.06 $196,863 - $273,605	-5,693 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$35.13 - $55.53 $3,618 - $5,719	-103 Reduced 1.78%	5,693 $257,000
Q1 2019 May 13, 2019	SELL	$42.83 - $59.91 $2,098 - $2,935	-49 Reduced 0.84%	5,796 $315,000
Q4 2018 Feb 05, 2019	BUY	$37.97 - $60.16 $221,934 - $351,635	5,845 New	5,845 $271,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cim Investment Management Inc with notifications on news.